Cancers caused by human papillomavirus (HPV), cervical, throat, head, neck, anal, penile and vaginal, remain a significant public health problem in the United States. Cervical cancer is the fourth most common cancer in women worldwide and an estimated 4,300 deaths from cervical cancer will occur in 2023 in the U.S. In addition to essential screening and early treatment, there is fortunately an HPV vaccine that protects against the types of HPV that cause most cervical and other HPV-associated cancers. It is a major advancement for all, since it offers primary prevention against the infectious agent that is the main cause. Data demonstrates that HPV vaccination could prevent more than 90% of HPV-caused cancers. Despite the demonstrated success of the HPV vaccine, vaccination along with screening rates still fall below national targets, and only worsened during the pandemic. Join us to learn how the HPV vaccine, screening and early treatment is a powerful tool to help end several cancers and actions that can be taken by Congress to help achieve increased uptake of these modalities throughout the nation.

Speakers:

• Rep. Kathy Castor (D-FL) 
• Rep. Julia Letlow (R-LA) 
• Rep. Kim Schrier, MD (D-WA)

Panelists:

• Beth Battaglino, RN-C: CEO, HealthyWomen
• Shobha Krishnan, MD, FAAFP: Founder and President, Global Initiative Against HPV and Cervical Cancer / Advocacy member, Union for International Cancer Control / Member, Advocacy Campaign Committee, International Papillomavirus Society / Board Member, American Medical Women’s Association (2019-2023)
• Heather M. Brandt, PhD: Director, HPV Cancer Prevention Program / Co-associate Director for Outreach, St. Jude Comprehensive Cancer Center / Member, Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital
• Tamika Felder: Chief Visionary,  Cervivor, Inc.
• Jason Mendelsohn: SupermanHPV / Member, Head and Neck Cancer Alliance Board of Directors
• Kathryn Kundrod, PhD, MPH: Senior Advisor for Cancer Moonshot Policy Coordination, White House Office of Science and Technology Policy